Instrument Inactif

Communiqués Novamind Inc.

Actions

NVMDF

CA67001F1045

Installations et services en soins de santé

Communiqués

14/12/22	Novamind : KCSA Mental Health Virtual Investor Conference	PU
07/12/22	Novamind : Water Tower Research Fireside Chat with Numinus	PU
28/11/22	Novamind : Numinus Fourth Quarter 2022 Results Conference Call	PU
02/11/22	Wonderland: Miami, hosted by Microdose	PU
13/10/22	Novamind : Water Tower Research Fireside Chat	PU
13/10/22	Novamind : Cantor Symposium on Mental Health Clinics	PU
13/06/22	CSE Bulletin: Delist -Novamind Inc. (NM)	NE
13/06/22	IIROC Trading Halt - NM	AQ
11/06/22	Novamind : Obtains Final Order for Plan of Arrangement from the Supreme Court of British Columbia and Completes Acquisition by Numinus Wellness Inc.	PU
08/06/22	Novamind : Shareholders Approve Proposed Acquisition by Numinus	PU
02/06/22	Novamind : Announces New Patient Financing Options	PU
31/05/22	Novamind : Reports Fiscal Q3 2022 Financial Results and Operating Highlights	PU
27/05/22	Novamind : Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders of Novamind Vote FOR the Proposed Plan of Arrangement	PU
02/05/22	Novamind : Announces Virtual Group Health Coaching	PU
12/04/22	IIROC Trade Resumption - NM	AQ
12/04/22	Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research	AQ
11/04/22	IIROC Trading Halt - NM	AQ
06/04/22	Novamind : Opens 8th Integrative Psychiatry Clinic	PU
16/03/22	Novamind : to Host MindMed Phase IIb Trial for LSD and Anxiety	PU
11/03/22	Novamind : Grants Restricted Share Units	PU
01/03/22	Novamind : Reports Fiscal Q2 2022 Financial Results and Operating Highlights	PU
22/02/22	Novamind : Publishes Psychedelic Therapy Patient Case Studies	PU
16/02/22	Novamind : Advances Clinical Pilot for Frontline KAP	PU
09/02/22	Novamind : Participates in Alto Neuroscience Phase II Clinical Trial for MDD and PTSD	PU
08/02/22	Novamind : Appoints Prakash Gowd as Chief Operating Officer	PU